Literature DB >> 19396074

Endoscopic interventions for weight loss surgery.

James C Ellsmere1, Christopher C Thompson, William R Brugge, Ram Chuttani, David J Desilets, David W Rattner, Michael E Tarnoff, Lee M Kaplan.   

Abstract

In this paper we review the state-of-the-art in endoscopic interventions for obesity treatment and make best practice recommendations for weight loss surgery (WLS). We performed a systematic search of English-language literature published between April 2004 and June 2008 in MEDLINE and the Cochrane Library on WLS and endoscopic interventions, endoscopically placed devices, minimally invasive surgery, image-guided surgery, endoluminal surgery, endoscopic instrumentation, interventional gastroenterology, transluminal surgery, and natural orifice transluminal surgery. We also searched the literature on endoscopic interventions and WLS and patient safety. We identified 36 pertinent articles, all of which were reviewed in detail; assessed the current science in endoscopic interventions for WLS; and made best practice recommendations based on the latest available evidence. Our findings indicate that endoscopic interventions and endoscopically placed devices may provide valuable approaches to the management of WLS complications and the primary management of obesity. Given the rapid changes in endoscopic technologies and techniques, systematic literature review is required to address issues related to the emerging role of endoluminal surgery in the treatment of obesity. These interventions should be a high priority for development and investigation.

Entities:  

Mesh:

Year:  2009        PMID: 19396074     DOI: 10.1038/oby.2008.588

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  9 in total

1.  Outcomes of revisional treatment modalities in non-complicated Roux-en-Y gastric bypass patients with weight regain.

Authors:  David Nguyen; Fernando Dip; Jorge A Huaco; Rena Moon; Hira Ahmad; Emanuele LoMenzo; Samuel Szomstein; Raul Rosenthal
Journal:  Obes Surg       Date:  2015-05       Impact factor: 4.129

2.  Treatment of weight regain following roux-en-Y gastric bypass: revision of pouch, creation of new gastrojejunostomy and placement of proximal pericardial patch ring.

Authors:  Rena C Moon; Andre F Teixeira; Muhammad A Jawad
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

3.  Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass.

Authors:  Panot Yimcharoen; Helen M Heneghan; Manish Singh; Stacy Brethauer; Philip Schauer; Tomasz Rogula; Matthew Kroh; Bipan Chand
Journal:  Surg Endosc       Date:  2011-04-30       Impact factor: 4.584

4.  Endoscopic management of gastrogastric fistulae does not increase complications at bariatric revision surgery.

Authors:  Michael S Flicker; David B Lautz; Christopher C Thompson
Journal:  J Gastrointest Surg       Date:  2011-04-09       Impact factor: 3.452

Review 5.  A review of the current status of endoluminal therapy as a primary approach to obesity management.

Authors:  Shounak Majumder; John Birk
Journal:  Surg Endosc       Date:  2013-01-24       Impact factor: 4.584

Review 6.  Benchmarking best practices in weight loss surgery.

Authors:  Robert B Lim; George L Blackburn; Daniel B Jones
Journal:  Curr Probl Surg       Date:  2010-02       Impact factor: 1.909

Review 7.  Role of Malabsorptive Endoscopic Procedures in Obesity Treatment.

Authors:  Jae Myung Park
Journal:  Clin Endosc       Date:  2017-01-30

8.  Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost.

Authors:  Guilherme M Campos; Charlotte Rabl; Sofia Peeva; Ruxandra Ciovica; Madhu Rao; Jean-Marc Schwarz; Peter Havel; Morris Schambelan; Kathleen Mulligan
Journal:  J Gastrointest Surg       Date:  2009-10-17       Impact factor: 3.452

Review 9.  Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease?

Authors:  H E Bays; B Laferrère; J Dixon; L Aronne; J M González-Campoy; C Apovian; B M Wolfe
Journal:  Int J Clin Pract       Date:  2009-09       Impact factor: 2.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.